Aspects of Peptidomimetics - Peptide and Protein Design for Biopharmaceutical Applications - page 109

[75] K. Sugase, M. Horikawan, M. Sugiyama and M. Ishiguro, Restriction of a peptide
turn conformation and conformational analysis of guanidino group using arginine-
proline fused amino acids: application to mini atrial natriuretic peptide on binding to
the receptor, J.Med.Chem ., 47, 489-492 (2004).
[76] C. Kadouri-Puchot and S. Comesse, Recent advances in asymmetric synthesis of
pipecolic acid and derivatives - Review article, Amino Acids , 29, 101-130 (2005).
[77] I. S. Kim, J. S. Oh, O. P. Zee and Y. H. Jung, Synthesis and conformational analysis of
3-hydroxypipecolic acid analogues via CSI-mediated stereoselective amination,
Tetrahedron , 63, 2622-2633 (2007).
[78] L. Le Corre and H. Dhimane, Synthesis of 5-substituted pipecolic acid derivatives as
new conformationally constrained ornithine and arginine analogues, Tetrahedron
Lett ., 46, 7495-7497 (2005).
[79] J. R. Casimir, K. Iterbeke, W. Van den Nest, M. C. Trescol-Biemont, H. Dumortier,
S. Muller, D. Gerlier, C. Rabourdin-Combe, D. Tourwe´ and J. Paris, Conformational
restriction of the Tyr(53) side-chain in the decapeptide HEL[52-61]: effects
on binding to MHC-II I-A(k) molecule and TCR recognition, J.Peptide Res ., 56,
398-408 (2000).
[80] P. Ruzza, L. Cesaro, D. Tourw ´, A. Calderan, B. Biondi, V. Maes, I. Menegazzo,
A. Osler, C. Rubini, A. Guiotto, L. A. Pinna, G. Borin and A. Donella-Deana, Spatial
conformation and topography of the tyrosine aromatic ring in substrate recognition
by protein tyrosine kinases, J.Med.Chem ., 49, 1916-1924 (2006).
[81] D. Tourw ´, K. Verschueren, A. Frycia, P. Davis, F. Porreca, V. J. Hruby, G. Toth,
H. Jaspers, P. Verheyden and G. VanBinst, Conformational restriction of Tyr and Phe
side chains in opioid peptides: Information about preferred and bioactive side-chain
topology, Biopolymers , 38, 1-12 (1996).
[82] W. M. Kazmierski, H. I. Yamamura and V. J. Hruby, Topographic design of peptide
neurotransmitters and hormones on stable backbone templates - relation of confor-
mation and dynamics to bioactivity, J.Am.Chem.Soc ., 113, 2275-2283 (1991).
[83] P. W. Schiller, G. Weltrowska, T. M. D. Nguyen, B. C. Wilkes, N. N. Chung
and C. Lemieux, TIPP[c] - A highly potent and stable pseudopeptide delta-opioid
receptor antagonist with extraordinary delta-selectivity, J.Med.Chem ., 36,

3182-3187 (1993).
[84] P. W. Schiller, G. Weltrowska, I. Berezowska, T. M. D. Nguyen, B. C. Wilkes,
C. Lemieux and N. N. Chung, The TIPP opioid peptide family: Development of
delta antagonists, delta agonists, and mixed mu agonist/delta antagonists,

Biopolymers , 51, 411-425 (1999).
[85] D. J. Kyle, J. A. Martin, S. G. Farmer and R. M. Burch, Design and conformational-
analysis of several highly potent bradykinin receptor antagonists, J.Med.Chem ., 34,
1230-1233 (1991).
[86] Z. X. Ye, T. MacNeil, D. H. Weinberg, R. N. Kalyani, R. Tang, A. M. Strack,
B. A. Murphy, R. T. Mosley, D. E. MacIntyre, L. H. T. Van der Ploeg, A. A. Patchett,
M. J. Wyvratt and R. R. Nargund, Structure-activity relationship of linear tetrapeptides
Tic-DPhe-Arg-Trp-NH 2 at the human melanocortin-4 receptor and effects on feeding
behaviors in rat, Peptides , 26, 2017-2025 (2005).
[87] K. X. Chen, F. G. Njoroge, J. Pichardo, A. Prongay, N. Butkiewicz, N. Yao,
V. Madison and V. Girijavallabhan, Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-
3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease,
J.Med.Chem ., 49, 567-574 (2006).